A team of clinician-scientists and scientists from the University of Nottingham (Malaysia campus), National Cancer Centre Singapore (NCCS), Cancer Research Malaysia, Nanyang Technological University, Singapore (NTU Singapore), University of Malaya, University of Cambridge, A*STAR's Genome Institute of Singapore (GIS) and other institutions, have...
Apr 26 2024SingHealth A team of clinician-scientists and scientists from the University of Nottingham , National Cancer Centre Singapore , Cancer Research Malaysia, Nanyang Technological University, Singapore , University of Malaya, University of Cambridge, A*STAR's Genome Institute of Singapore and other institutions, have conducted the largest study done to date of BRCA1 and BRCA2 carriers in an Asian population and refined breast and ovarian cancer risk estimates for this population.
To address this pressing clinical need, a multidisciplinary team of clinician-scientists, scientists and genetic counselors, studied the clinical data of 572 families in Singapore and Malaysia with BRCA1 and BRCA2 mutations. The family members were 20 to 79 years old and of Chinese, Indian and Malay ethnicity. Of the 1,121 BRCA1 carriers, 144 and 65 were diagnosed with breast and ovarian cancer, respectively.
The cumulative risks of Chinese BRCA1 and BRCA2 carriers in Singapore developing breast and ovarian cancers were similar to Asians in the United States but higher compared to Chinese in Malaysia. The cumulative risks of Indian BRCA1 and BRCA2 carriers in Singapore were similar to Asians in UK but higher compared to Indians from Malaysia.
Gene Breast Cancer Cancer Genes Genetic Genome Germline Medicine Mortality Oncology Oophorectomy Ovarian Cancer Precision Medicine Proton Therapy Research
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Cancer on campus: Over 150 students and staff at North Carolina university 'are diagnosed with host...More than 150 cancer cases have been linked to Poe Hall, a class building at North Carolina State University in Raleigh. Reports found high levels of the cancer-causing cehmicals PCBs.
続きを読む »
Shape-shifting cancer cell discovery reveals potential skin cancer drug targetsCancer cells can change shape to travel around the body and spread (metastasize), but how they know when to do this has remained elusive.
続きを読む »
Risk for second primary breast cancer low in certain young breast cancer patientsYoung breast cancer (BC) survivors (40 years or younger) without a pathogenic variant (PV) have a low risk for developing second primary BC (SPBC), according to a study published online April 11 in JAMA Oncology.
続きを読む »
New Lancet Commission on Breast Cancer: Transforming breast cancer care globallyThe new Lancet Commission on Breast Cancer today released findings and recommendations on improving breast cancer care globally.
続きを読む »
Targeted liver cancer treatment kills cancer cells and could cut chemo side effectsDrug-loaded 3D printed films could change cancer treatments forever as world first research from the University of South Australia shows that new films not only kill more than 80% of liver cancer cells but could also significantly reduce recurrence rates while minimizing systematic toxicities of traditional chemotherapy.
続きを読む »
Clinical trial data show investigational cancer vaccine may elicit lasting immune response in pancreatic cancerNew data presented by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after...
続きを読む »